Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 745–768 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Kidney Diseases
Interventions: Kidney Transplant Fast Track (KTFT), Peer Navigation (PN); Other
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Acute Decompensated Heart Failure
Interventions: Reprieve Decongestion Management System, Diuretic; Device · Drug
Lead sponsor: Reprieve Cardiovascular, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 16
States / cities: Fairhope, Alabama • Irvine, California • Washington D.C., District of Columbia + 12 more

Conditions: Psoriasis
Interventions: Observational (Non-Interventional) Registry; Other
Lead sponsor: CorEvitas; Network
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding
Interventions: Removable Rapid Palatal Expander, Banded Palatal Expander; Device
Lead sponsor: Align Technology, Inc.; Industry
Eligibility: 6 Years to 11 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Laguna Hills, California • Warner Robins, Georgia • Naperville, Illinois + 1 more

Conditions: Major Depressive Disorder
Interventions: Genotype-guided care; Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 95 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Lung Cancer
Interventions: Enhanced lung cancer screening services; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 50 Years to 80 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Volunteers, Healthy Volunteers, Human Volunteers, Normal Volunteers
Interventions: Entinostat; Drug
Lead sponsor: Syndax Pharmaceuticals; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Prostate Cancer
Interventions: ADT Order Check Attestation (Or), Provider Script (Sc); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: SARS-CoV-2 Acute Respiratory Disease, Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Post-acute Sequelae of SARS-COV-2 Infection, Post COVID-19 Condition
Interventions: Extension for Community Healthcare Outcomes; Other
Lead sponsor: Family Health Centers of San Diego; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Fibrodysplasia Ossificans Progressiva
Interventions: Palovarotene, midazolam; Drug
Lead sponsor: Clementia Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Healthy
Interventions: Leptin administration, Fasting; Drug · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2003
U.S. locations: 2
States / cities: Boston, Massachusetts • Cambridge, Massachusetts

Conditions: Wild Type BRAF Stage IV Melanoma, Unresectable Stage III Melanoma
Interventions: TMZ, E7016; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Lymphoma
Interventions: milatuzumab, veltuzumab, Correlative/Special Studies, Quantitative T-, B-, and NK cell subsets, Pharmacokinetics, Human Anti-Human Antibodies, veltuzumab and milatuzumab; Biological · Procedure
Lead sponsor: Beth Christian; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Blood Pressure Control
Interventions: ACT-BP Intervention; Other
Lead sponsor: Elizabeth Pfoh; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Cleveland, Ohio • Mayfield Heights, Ohio

Conditions: Pain, Postoperative
Interventions: Waveguard (TM) EEG cap, Micro Movement Sensor, Pico Movement Sensor, QS Piezostimulator, tactileTM sensory evaluator; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 1 Hour to 6 Months
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Covid19
Interventions: Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional); Diagnostic Test
Lead sponsor: Nanomix; Industry
Eligibility: 18 Years and older
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Emeryville, California

Conditions: Major Depressive Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 50 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Acute Respiratory Infections (ARIs)
Interventions: Rapid point of care test to detect host immune response in ARI; Diagnostic Test
Lead sponsor: Lumos Diagnostics; Industry
Eligibility: 12 Years to 64 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Fullerton, California • Pasadena, California • Miami, Florida + 5 more

Conditions: Healthy Volunteer
Interventions: GDC-0310, Placebo; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Schizophrenia
Interventions: Cognitive enhancement therapy (CET), Enriched supportive therapy (EST); Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 16 Years to 51 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Schizophrenia, Schizoaffective Disorder, Major Depression, Bipolar Disorder, Anxiety Disorder
Interventions: Thinking Skills for Work Program, Supported Employment; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Chicago, Illinois • Manchester, New Hampshire

Conditions: Physician-Patient Relations, Communication Research
Interventions: Relevant Patient Reported Outcome Measures (PROMs), My Whole Health Map; Behavioral · Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 89 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Menstrual Irregularity
Interventions: Artificially Sweetened Carbohydrate Beverage, Artificially Sweetened Beverage; Dietary Supplement
Lead sponsor: University of Colorado, Colorado Springs; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Colorado Springs, Colorado

Conditions: Healthy
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Access to Kidney Transplantation in Minority Populations

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)

PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

Hyrax Vs. Invisalign Palatal Expander Clinical Study

Pharmacogenetic Decision Support IT System for Psychiatric Hospitalization: RCT

Tribally Engaged Approaches to Lung Screening (TEALS)

Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat

DeADT - Living Well With Prostate Cancer

Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?

Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects

Secondary Analysis of Gut Hormones and Inflammatory Cytokines in Fasting Subjects

Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes

Innovative Approaches to Assessment of Pain Control and Sedation in the NICU

Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects

Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study

FebriDx® Method Comparison Study Protocol

A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers

Cognitive Enhancement Therapy for Early-Stage Schizophrenia

Thinking Skills for Work in Severe Mental Illness

Measuring and Displaying the Subjective

Timing of Energy Availability on Menstrual Cycle Function

Normal Human Electro-Oculogram